Advisor Partners II’s Maravai LifeSciences MRVI Stock Holding History

Advisor Partners II’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$115K	Buy	+11,459	New	+$126K	﹤0.01%	1226

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Advisor Partners II's MRVI Position: Q3 2023 in Review

Advisor Partners II opened a new position in Maravai LifeSciences (MRVI) in Q3 2023: 11,459 shares worth $115K. The stake represents ﹤0.01% of the portfolio and ranks #1226 among its holdings.

204 funds tracked by Wall St. Rank hold MRVI as of Q3 2023.

Advisor Partners II held 11,459 shares of Maravai LifeSciences worth $115K as of Q3 2023.
Maravai LifeSciences was a new Advisor Partners II position in Q3 2023.
Maravai LifeSciences made up ﹤0.01% of Advisor Partners II's portfolio in Q3 2023, its #1226 holding.
204 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.